Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: J Thromb Haemost. 2012 Feb;10(2):177–188. doi: 10.1111/j.1538-7836.2011.04571.x

Figure 1. Cells, matrix factors and metabolic constituents contributing to osteoblastic and vascular bone marrow niches.

Figure 1

The osteoblastic niche. Osteoblasts and osteoclasts secrete numerous factors that regulate haematopoietic stem cells (HSCs; dark blue). Bone resorption releases calcium ions (Ca2+) influencing HSCs through the Ca2+-sensing receptor. The endosteal surface is also heavily invested with blood vessels. Vascular and perivascular cells, such as CXCL12 (SDF1)-producing reticular cells (CAR) and mesenchymal stem cells (MSCs) are also thought to contribute to HSC niches at the endosteum. The relative hypoxia and abundance of Type I collagen inhibit proplatelet formation by megakaryocytes.

The vascular niche. Perivascular sites maintain HSCs and haematopoietic progenitor cells (HPCs; lighter blue) in the bone marrow and in extramedullary sites including spleen, liver and the placenta. A wide variety of vascular and perivascular cells are likely to contribute to vascular niches, including endothelial cells, CAR cells/MSCs and possibly megakaryocytes. Matrix factors fibronectin, vitronectin and Type III and IV collagen are found around blood vessels, which enhance megakaryocyte development and function.